Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy

Published:2022-09-12 Issue: Volume: Page:
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Eng Stefan E.^ORCID,Basasie Benjamin,Lam Alfonso,John Semmes O.,Troyer Dean A.,Clarke Geoffrey D.^ORCID,Sunnapwar Abhijit G.,Leach Robin J.,Johnson-Pais Teresa L.,Sokoll Lori J.^ORCID,Chan Daniel W.,Tosoian Jeffrey J.,Siddiqui Javed,Chinnaiyan Arul M.,Thompson Ian M.,Boutros Paul C.^ORCID,Liss Michael A.^ORCID

Funder

United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Division of Cancer Prevention, National Cancer Institute

SPORE Career Enhancement Program

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

https://www.nature.com/articles/s41391-022-00591-w.pdf

Reference30 articles.

1. Johansson J-E, Andrén O, Andersson S-O, Dickman PW, Holmberg L, Magnuson A, et al. Natural history of early, localized prostate cancer. JAMA. 2004;291:2713–9.

2. Mohler JL, Antonarakis ES, Armstrong AJ, D’Amico AV, Davis BJ, Dorff T, et al. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019;17:479–505.

3. Cooperberg MR, Zheng Y, Faino AV, Newcomb LF, Zhu K, Cowan JE, et al. Tailoring intensity of active surveillance for low-risk prostate cancer based on individualized prediction of risk stability. JAMA Oncol. 2020;6:e203187.

4. Detsky JS, Ghiam AF, Mamedov A, Commisso K, Commisso A, Zhang L, et al. Impact of biopsy compliance on outcomes for patients on active surveillance for prostate cancer. J Urol. 2020;204:934–40.

5. Klotz L, Loblaw A, Sugar L, Moussa M, Berman DM, Van der Kwast T, et al. Active Surveillance Magnetic Resonance Imaging Study (ASIST): results of a randomized multicenter prospective trial. Eur Urol. 2019;75:300–9.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Restriction Spectrum Imaging and Diffusion Kurtosis Imaging for Assessing Proliferation Status in Rectal Carcinoma;Academic Radiology;2024-08

2. A Pilot Study on Patient-specific Computational Forecasting of Prostate Cancer Growth during Active Surveillance Using an Imaging-informed Biomechanistic Model;Cancer Research Communications;2024-03-01

3. Prostate MRI for the detection of clinically significant prostate cancer: Update and future directions;Advances in Cancer Research;2024

4. Recent advances and future perspectives in the therapeutics of prostate cancer;Experimental Hematology & Oncology;2023-09-22

5. Role of Perilesional Sampling of Patients Undergoing Fusion Prostate Biopsies;Life;2023-08-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3